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Abstract  1 
Effective disinfectants are of key importance for the safe handling and reprocessing of 2 
surgical instruments. We tested whether new formulations containing SDS, NaOH and 1-3 
propanol (n-propanol) are simultaneously active against a broad range of pathogens including 4 
bacteria, fungi, non-enveloped viruses and prions. Inactivation and disinfection were 5 
examined in suspension and on carriers, respectively, using coagulated blood or brain 6 
homogenate as organic soil. Coomassie blue staining was used to assess whether formulations 7 
did undesirably fix proteins to rough surfaces. A mixture of 0.2% SDS and 0.3% NaOH in 8 
20% n-propanol achieved potent decontamination of steel carriers contaminated with PrPTSE, 9 
the biochemical marker for prion infectivity, from 263K scrapie hamsters, or patients with 10 
sporadic or variant Creutzfeldt-Jakob disease. 263K scrapie infectivity on carriers was 11 
decreased by ≥5.5 log10 units [logs]. Furthermore, the formulation effectively inactivated 12 
poliovirus, hepatitis A virus and caliciviruses (including murine norovirus) in suspension 13 
tests. It also yielded significant titre reductions of bacteria (E. faecium, M. avium; >6 logs), 14 
fungi (spores of Aspergillus niger; >5 logs) or poliovirus (≥4 logs) embedded in coagulated 15 
blood on carriers. The formulation was not found to fix proteins more than was observed with 16 
water as cleaning reagent.  SDS, NaOH and n-propanol can synergistically achieve fast broad-17 
range disinfection.  18 
 3




Effective disinfection is of utmost importance in the maintenance of re-usable surgical 2 
instruments. In this context, an ideal disinfectant applicable also to heat sensitive devices 3 
should have a fast and broad-range activity on bacteria, viruses, fungi as well as prions while 4 
being easy to use and free of effects that fix (i. e. bind) organic soil containing proteins to the 5 
surface of instruments. Such requirements cannot be met readily since a variety of pathogens 6 
such as mycobacteria, fungal spores, non-enveloped viruses (like poliovirus) and last but not 7 
least prions are known for their unusually high tolerance to inactivation (Beekes et al., 2004; 8 
Fernie et al., 2007; Rutala et al., 2008; Taylor, 2004).  9 
Prions, “proteinaceous infectious particles” (Prusiner, 1982), are considered as the causative 10 
agents of transmissible spongiform encephalopathies (TSEs) such as scrapie in sheep, bovine 11 
spongiform encephalopathy (BSE) in cattle, or Creutzfeldt-Jakob disease (CJD) and its 12 
variant form (vCJD) in humans. According to the prion hypothesis these agents are composed 13 
essentially – if not entirely – of misfolded prion protein (PrP) which is derived from a host-14 
encoded cellular precursor (PrPC) (Prusiner, 1998). The deposition in the central nervous 15 
system of disease-associated prion protein, referred to as PrPSc (Prusiner, 1998) or PrPTSE 16 
(Brown & Cervenakova, 2005), with an abnormal folding and/or aggregation structure is a 17 
pathological hallmark of TSEs, and PrPTSE has been used in many studies as a molecular 18 
marker for prion infectivity (Beekes & McBride, 2007).   19 
The study described in this report emanated from previous work in which we tested various 20 
formulations for their ability to detach, destabilize or degrade PrPTSE attached to steel wires 21 
and to inactivate prion infectivity on such carriers. Similar steel wire models for prion 22 
disinfection of surgical instruments (Flechsig et al., 2001; Zobeley et al., 1999) have also 23 
been employed by other research groups (Fichet et al., 2004; Fichet et al., 2007; Yan et al., 24 
2004). In our previous studies we identified a formulation of 0.2% SDS and 0.3% NaOH (in 25 
the following referred to as SDS/NaOH) as a highly potent disinfectant against 263K scrapie 26 
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agent from hamsters (Lemmer et al., 2004; Lemmer et al., 2008). We have now explored 1 
whether, by adding different concentrations of ethanol or n-propanol to this formulation, its 2 
protein-destabilizing and prion inactivating activity may be extended to disinfection of 3 
bacteria, viruses and fungi without causing effects that would undesirably fix proteins. 4 
 5




Efficacy testing of formulations against bacteria, fungi and viruses 2 
Test organisms and nutrient media (in brackets) 3 
Enterococcus faecium DSM 2146 (Brain Heart-Infusion-Agar), Mycobacterium avium DSM 4 
44156 (Middlebrook 7H10 Agar with OADC [Oleic acid, albumin fraction V / bovine, 5 
dextrose, catalase / beef] enrichment), Aspergillus niger ATCC 16404 (Malt Extract Agar); 6 
Feline calicivirus (FCV) strain F-9 in CrFK cells, Poliovirus type I LSc-2ab (PV) in L20B 7 
cells, Hepatitis A virus (HAV) strain HM 175cyt in RHK cells (MEM [minimum essential 8 
medium] with Hanks salt solution for FVC, PV and HAV), Murine Norovirus (MNV) strain 9 
S99 in RAW 264.7 cells (modified Dulbecco´s MEM (Park et al., 2007)). 10 
11  
Formulations used for disinfection 12 
a) 0.2% (w/v) SDS, 0.3% (w/v) NaOH (in double distilled water [ddH2O]), 13 
b) 0.2% (w/v) SDS, 0.3% (w/v) NaOH, 50% (v/v) ethanol (in ddH2O),  14 
c) 0.2% (w/v) SDS, 0.3% (w/v) NaOH, 30% (v/v) n-propanol (in ddH2O), 15 
d) 0.2% (w/v) SDS, 0.3% (w/v) NaOH, 20% (v/v) n-propanol (in ddH2O), 16 
e) 50% (v/v) ethanol (in ddH2O),  17 
f) 20% (v/v) n-propanol (in ddH2O), 18 
g) 2% (v/v) glutardialdehyde (in ddH2O), 19 
h) 0.35% (v/v) peracetic acid (in ddH2O), 20 
i) sodium hypochlorite (NaOCl) solution with 20.000 ppm available chlorine (in ddH2O).  21 
22  
Microbial test suspensions 23 
E. faecium 24 
Subcultured preparations of E. faecium were pelleted, washed and diluted in ddH2O to 25 
achieve suspensions containing at least 109 colony forming units (CFU)/ml.  26 
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M. avium 1 
Subcultured preparations of M. avium were pelleted and washed in 0.1% (v/v) Tween 80 in 2 
ddH2O. After resuspension using a glass/Teflon homogenizer the bacterial solution was 3 
adjusted to a concentration of at least 109 CFU/ml.  4 
A. niger 5 
After sporulation spores were harvested with 0.05% (v/v) polysorbate 80 in distilled water 6 
(dH2O). The fungal suspensions were adjusted to 10
8 - 109 CFU/ml.  7 
8  
Viruses 9 
Confluent monolayers of CrFK-, L20B-, RHK- or RAW 264.7 cells in culture flasks were 10 
infected with FCV, PV, HAV or MNV, respectively. Supernatants were harvested after 5 days 11 
(PV, MNV and FCV) or 14 days (HAV) and concentrated by ultracentrifugation. Infectious 12 
titers of virus suspensions were in the range of 108 – 109 TCID50/ml. 13 
14  
Quantitative suspension tests  15 
Formulations a–f were applied in an Eppendorf Thermomixer at 20°C to preparations of all 16 
test organisms specified above. Suspensions of the respective test organisms and disinfectants 17 
were mixed at a ratio of 1:10. Suspension tests with poliovirus and hepatitis A virus were also 18 
performed with an additional organic burden of 10% (v/v) fetal calf serum, and all solutions 19 
were incubated for 20 minutes under constant shaking (300 rpm). As controls, suspensions of 20 
the test organisms were exposed to ddH2O only. 21 
22  
Recovery of bacteria and fungi  23 
After incubation for 20 minutes samples were immediately centrifuged (12000 x g, 1 minute); 24 
pellets were harvested and resuspended in equivalent quantities of 0.1 M phosphate buffer  25 
pH 7 (containing 3 % [v/v] Tween 80 in case of mycobcteria and A. niger). Subsequently, 26 
 7
Beekes et al., Manuscript for Journal of General Virology 
 
 
samples were serially diluted 1:10 in the respective phosphate buffer. From the undiluted test 1 
mixtures and their serial dilutions, 0.1 ml aliquots were spread on nutrient media, or in the 2 
case of enterococci mixed with nutrient media (1 ml per petri dish). Incubation was performed 3 
at 36°C for bacteria, and at 30°C for A. niger. 4 
The efficacy of disinfection was indicated by the reduction factor (RF): From the average 5 
number of CFUs observed after exposure of test organisms to the respective disinfectant (log 6 
N) and the number of CFUs observed for the control samples exposed to ddH2O (log N0) the 7 
reduction factor was calculated as follows: RF = log N0 – log N. 8 
9  
Recovery of viruses 10 
After incubation for 20 minutes 1:10 serial dilutions of samples were performed using 11 
nutrient cell culture media as diluents. Inactivation of viruses was determined using TCID50-12 
assays on 96 well plates. 100 µl of the various dilutions each were added to confluent 13 
monolayers and cytopathic effects were determined after 5 days (PV, FCV, MNV) or 14 days 14 
(HAV). Virus titers were calculated according to the method of Spearman and Kärber 15 
(Kärber, 1931;Spearman, 1908). 16 
17  
Quantitative carrier tests 18 
Quantitative carrier tests were performed according to a method established at the Robert 19 
Koch-Institut, Germany (1995). Briefly: Sterilized frosted glass strips were used as carriers. 20 
Suspensions of test organisms were mixed with heparinised sheep blood. Immediately before 21 
application onto the carriers, Protamin 1000 had been added to the blood suspensions for 22 
coagulation. When coagulation of the blood was accomplished carriers were incubated in  23 
10 ml of the different disinfectant formulations. After exposure to disinfectant formulations, 24 
residual contaminations of test organisms in blood were carefully harvested from the carriers. 25 
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Recovery of bacteria, fungi and viruses and the calculation of reduction factors were 1 
performed as described for quantitative suspension tests.    2 
3  
Efficacy testing of formulations against prions 4 
In vitro carrier assays with PrPTSE 5 
Decontamination of steel carriers from PrPTSE of 263K scrapie agent was tested in an in vitro 6 
carrier assay as described previously for SDS/NaOH (Lemmer et al., 2004). Similar in vitro 7 
studies on the decontamination of steel carriers from PrPTSE of patients with sporadic CJD 8 
(sCJD) or vCJD were performed with the following modifications: Stainless steel wire grids 9 
(DIN 1.4301; Spörl, Sigmaringendorf, Germany) measuring about 100mm x 5mm were 10 
contaminated with 25% (w/v) brain tissue homogenate from a patient with sporadic CJD (type 11 
MM1; kindly provided by W. Schulz-Schaeffer, Universitätsklinikum Göttingen, Germany) 12 
or from a patient with vCJD (kindly provided by the CJD Surveillance Unit, Edinburgh, UK). 13 
After drying, grids were incubated in 45 ml of the disinfectant formulations, or water, for 5 14 
min (vCJD) or 20 min (sCJD). Subsequently, grids were washed and dried (Lemmer et al., 15 
2004), coiled up and treated with 300 µl Proteinase K solution (PK, 20 µg/ml) in TBS-16 
Sarkosyl (50 mM Tris/HCl, 150 mM NaCl pH 7.5, 1% Sarcosyl) for 10 min (vCJD) or 20 min 17 
(sCJD) at 37°C. After PK digestion, samples were mixed with 100 µl of 4 x electrophoresis 18 
sample loading buffer, boiled for 10 min, and analysed by SDS-PAGE and Western-blotting 19 
for the presence of PrPTSE using the monoclonal antibody 3F4 as previously described 20 
(Lemmer et al., 2004). If not otherwise specified, 25 l aliquots were used for Western 21 
blotting. The studies on tissue samples from human donors were performed in compliance 22 
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Bioassays with 263K scrapie agent  1 
The disinfection of steel wires contaminated with 263K prion infectivity was examined in 2 
vivo. For this purpose contamination of wires, processing for decontamination in SDS/NaOH 3 
containing 20% or 30% n-propanaol, bioassays in hamsters using a dose-response relationship 4 
established by end-point titration, and PET blotting were performed as recently described 5 
(Lemmer et al., 2008). The bioassays on the SDS/NaOH/n-propanol formulations were 6 
carried out in duplicate (bioassay group 1 and bioassay group 2). The studies in animals 7 
complied with German legal regulations and were approved by the responsible ethic 8 
committees and regulatory authorities.    9 
10  
Analysis of whether formulations used for disinfection fix protein to rough surfaces 11 
We examined whether formulations a, d, g, h and i - as compared to water - did additionally 12 
fix protein to rough test surfaces, using frosted glass strips as carriers. The carriers were 13 
contaminated with 10% (w/v) 263K scrapie brain homogenate or sheep blood capable of 14 
coagulation (see quantitative carrier test). After contamination, carriers were separately 15 
immersed in 10 ml each of the different disinfectant formulations at 20°C for 30 minutes. 16 
After rinsing with dH2O, the glass strips were immersed at room temperature for 45 minutes 17 
in 15 ml Coomassie blue solution. Finally, the glass strips were rinsed 4-5 times in destaining 18 
solution (50% [v/v] methanol, 10% [v/v] acetic acid in dH2O). In each series of stainings a 19 
non-contaminated glass strip was processed similarly as a negative control for comparison.  20 
21  
 10




Efficacy of the tested formulations against bacteria, fungi and viruses 2 
The efficacy of candidate formulations was tested using a broad range of conventional 3 
pathogens known to be highly tolerant to conventional disinfectants, like enterococci, 4 
Mycobacterium avium, norovirus, poliovirus, HAV, and spores of Aspergillus niger. Since the 5 
activity against infective agents embedded in proteinacous matrices was of utmost interest, 6 
tests using carriers contaminated with pathogens in coagulated blood were performed. 7 
Additional suspension tests (some samples of which contained an additional organic burden 8 
of 10% fetal calf serum [FCS]) were carried out to corroborate findings obtained with carrier 9 
assays.  10 
11  
Efficacy against enterococci and mycobacteria 12 
The efficacy against mycobacteria and enterococci was examined in a quantitative carrier test 13 
using coagulated blood as test soil (Table 1). While SDS/NaOH without alcohol showed no 14 
relevant inactivating effect, the addition of 50% ethanol or 20% n-propanol resulted in 15 
reduction factors of > 6 logs. All formulations found to be effective in the carrier test were 16 
also at least as active when assessed in quantitative suspension tests (data not shown). 17 
18  
Efficacy against non-enveloped viruses 19 
Virucidal activities of the various formulations were initially assessed for a broad range of 20 
viruses including vacciniavirus (VV), simian virus 40 (SV40), adenovirus (AV), caliciviruses 21 
(feline calicivirus and murine norovirus) or poliovirus in quantitative suspension tests. 22 
Caliciviruses, poliovirus and HAV were identified as the most tolerant viruses in these assays 23 
(data not shown for other viruses), and poliovirus was subsequently also used in quantitative 24 
carrier tests with coagulated blood as test soil. The findings with poliovirus, HAV and 25 
caliciviruses are summarized in Table 2.  26 
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In contrast to the results with bacteria, ethanol or propanol alone did not exert a relevant 1 
inactivating effect on these viruses. However, when 20% n-propanol was used in a mixture 2 
with SDS/NaOH reduction factors of 4 logs or more were observed in quantitative suspension 3 
tests for caliciviruses, hepatitis A virus (with 10% FCS as additional organic burden) or 4 
poliovirus (with or without 10% FCS as additional organic burden), and in the quantitative 5 
carrier test with coagulated blood for poliovirus.  6 
7           
Efficacy against spores of Aspergillus niger 8 
Neither SDS/NaOH, nor 50% ethanol or 20% n-propanol alone were able to achieve a 9 
significant disinfection of carriers contaminated with Aspergillus niger spores (Table 3). 10 
However, strong synergistic effects in terms of disinfection were observed, yielding reduction 11 
factors of > 5 logs, when formulations of SDS/NaOH in 50% ethanol or 20% n-propanol were 12 
applied.       13 
14  
Efficacy of the tested formulations against prions     15 
Alcoholic mixtures of SDS/NaOH were tested in vitro for their potential to decontaminate 16 
steel carriers from PrPTSE that had been coated with brain homogenates of scrapie hamsters or 17 
patients with sporadic or variant Creutzfeldt-Jakob disease. The disinfection by these 18 
formulations of steel wires contaminated with 263 K scrapie agent was monitored in hamster 19 
bioassays.   20 
21  
Decontamination of steel wires from PrPTSE of 263K scrapie hamsters 22 
As described previously (Lemmer et al., 2004) the efficacy of the decontamination of steel 23 
wires from PrPTSE was assessed in vitro by comparing the initial load of contamination on the 24 
wires with the amount of total PrP and PrP27-30 (the proteinase K resistant core of PrPTSE) 25 
residually attached to the carriers after processing in the test solutions. According to the 26 
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established sensitivity of our assay a complete disappearance of PrPTSE staining in eluates 1 
from the wires with or without PK-treatment indicated a 500-1000 fold reduction of PK-2 
resistant PrP or total PrP, respectively.  3 
When contaminated steel wires were processed in a mixture of SDS/NaOH containing 50% 4 
ethanol a strong signal for residual PrP was observed after incubation for 5 min (Fig. 1A, lane 5 
1), and after 20 min of incubation weak staining for PrP was still visible without PK digestion 6 
(Fig. 1A, lane 3). After PK digestion, a complete disappearance of residual PrPTSE could be 7 
observed (Fig. 1A, lanes 2 and 4). When 50% n-propanol was used instead of 50% ethanol in 8 
the mixture, residual staining of PrP was less intense after 5 min (Fig. 1B, lane 1) and nearly 9 
absent after 20 min of incubation (Fig. 1B, lane 3). After digestion with PK, immunostaining 10 
of residual PrPTSE completely disappeared (Fig. 1B, lanes 2 and 4). These findings indicated 11 
that 50% n-propanol and particularly 50% ethanol in the solution caused effects that fixed 12 
PrPTSE as compared to SDS/NaOH alone [14]. 13 
We therefore focussed subsequently on n-propanol and lowered its concentration in 14 
SDS/NaOH to 30% or 20%. This led to a virtually complete disappearance of specific PrP 15 
immunostaining both without and after PK treatment after incubation for 5 or 10 min (Fig. 1C 16 
and D). Obviously, lowering the concentration of n-propanol in SDS/NaOH to 30% or 20% 17 
counteracted effects of the alcoholic component that fixed proteins and restored the efficacy 18 
of wire decontamination to the level previously observed for SDS/NaOH without alcohol 19 
[14]. Thus, in the next step, we validated the prion disinfecting activity of SDS/NaOH in 20 20 
% or 30 % n-propanol by steel wire bioassays.      21 
22  
Bioassay of the disinfection of steel wires contaminated with 263K scrapie agent 23 
For bioassay validation we used a recently published in vivo carrier assay (Lemmer et al., 24 
2008). Contaminated wires were implanted intracerebrally into hamsters after reprocessing in 25 
the test mixtures and monitored for their potential to trigger clinical or subclinical (i. e. 26 
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asymptomatic) infection within an observation period of 500 days. The animals of the positive 1 
control group challenged with implanted contaminated wires that had been rinsed in dH2O 2 
only developed terminal scrapie after a survival time of 86±3 (mean±SD) days. According to 3 
our previously established dose-response relationship (Lemmer et al., 2008) this confirmed an 4 
initial infectivity load of ≥ 3x105 LD50i.c.imp per wire. In contrast, all animals which received 5 
wires treated in SDS/NaOH containing 20% or 30% n-propanol stayed free of clinical scrapie 6 
symptoms until termination of the experiment at 503 days after wire implantation (Table 4; a 7 
total of n=5 animals was excluded from the titration assay due to intercurring death unrelated 8 
to scrapie). No subclinical infection could be detected by PET blotting for cerebral PrPTSE in 9 
any of the animals that survived without scrapie symptoms until 503 days post implantation 10 
(not shown). These findings indicated a reduction in infectivity of ≥ 5.5 log10 units (logs). 11 
Thus, the addition of 30% or 20% n-propanol did not compromise the prion disinfecting 12 
activity previously observed for SDS/NaOH alone (Lemmer et al., 2008).    13 
14  
Decontamination of steel wires from PrPTSE of patients with sporadic and variant CJD 15 
In order to examine the effect SDS/NaOH containing 30% or 20% n-propanol on human 16 
PrPTSE in vitro, we used steel wire grids coated with brain homogenates from patients with 17 
sCJD or vCJD as test carriers. For contamination of grids with sCJD material, brain 18 
homogenate from a patient with the most frequent subtype of sporadic CJD (MM1, i. e. 19 
PrPTSE type 1, homozygous genotype for methionine at codon 129 of the prion protein gene 20 
(Heinemann et al., 2007)) was used. By using steel wire grids (that provided a larger surface 21 
for PrPTSE binding than steel wires) as test carriers we were able to monitor depletion of 22 
PrPTSE over a range of 3.3 logs (Fig 2, lanes 1-5 in A, and lanes 1-4 in B). With this modified 23 
in vitro assay no residual immunostaining for PrPTSE could be detected after processing in the 24 
SDS/NaOH solution containing 20% n-propanol (Fig 2A, lane 6 and Fig 2B, lane 5) for 20 25 
min (sCJD) or even only 5 min (vCJD). This indicated an at least 2000-fold reduction of the 26 
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PrPTSE load on the carriers by this formulation. However, when the SDS/NaOH mixture used 1 
for decontamination contained 30% instead of 20% n-propanol, a residual signal of sCJD-2 
associated PrPTSE was observed (Fig 2A, lane 7), indicating a binding or stabilization of this 3 
specific form of PrPTSE by the higher concentrated alcohol which did not occur with vCJD 4 
material (Fig 2B, lane 6). This binding/stabilizing effect could be omitted by incubation of the 5 
sCJD brain homogenate on the grids for 20 min in SDS/NaOH alone (Fig 2A, lane 8), with or 6 
without subsequent treatment, again for 20 min, in SDS/NaOH containing 30% n-propanol 7 
(Fig 2A, lane 9).       8 
9  
Assessment of whether formulations used for disinfection fix protein to rough carrier 10 
surfaces 11 
The formulations were further assessed in a qualitative assay for effects that fix proteins to 12 
rough test surfaces. For this purpose, residual protein from hamster brain homogenate or 13 
coagulated sheep blood on frosted glass strips was stained with Coomassie blue after 14 
processing in disinfectant formulations (Fig 3).  15 
Findings for blood: The visual examination of our assay results revealed that incubation in 16 
glutardialdehyde (Fig 3, lower panel, lanes 1&2) or peracetic acid (Fig 3, lower panel, lanes 17 
3&4) resulted in the detection of more coloured organic material on the carrier surfaces as 18 
found for water (Fig 3, lower panel, lanes 11&12). The blood sample treated with 19 
glutardialdehyde did not show a blue, but a red/black staining. NaOCl produced only a very 20 
weak blue staining (Fig 3, lower panel, lanes 5&6), and blood contaminated carriers which 21 
were incubated in SDS/NaOH (Fig 3, lower panel, lanes 7&8) or SDS/NaOH containing 20% 22 
n-propanol (Fig 3, lower panel, lanes 9&10) did not show a stronger coomassie blue staining 23 
than that observed after cleaning with water (Fig 3, lower panel, lanes 11&12). 24 
Findings for hamster brain homogenate: When brain homogenate was used as organic soil 25 
instead of blood, only a faint blue staining was found after treatment in glutardialdehyde (Fig 26 
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3, upper panel, lanes 1&2) while incubation in peracetic acid (Fig 3, upper panel, lanes 3&4) 1 
again produced a strong blue staining signal. With NaOCl or SDS/NaOH no residual staining 2 
was observed (Fig 3, upper panel, lanes 5&6 and 7&8, respectively). A weak blue staining of 3 
glass carriers after incubation in the formulation of 0.2%SDS, 0.3% NaOH and 20% n-4 
propanol (Fig 3, upper panel, lanes 9&10) indicated residual binding of brain homogenate 5 
proteins on the carrier surface, but as for blood this formulation did not produce a stronger 6 
coomassie blue staining than that observed with water (Fig 3, upper panel, lanes 11&12). 7 
Similarly processed non-contaminated glass strips consistently produced negative results (Fig 8 
3, upper and lower panel, lane 13).  9 
 16




Efficacy of tested formulations for broad-range disinfection 2 
We found that a formulation of 0.2% SDS and 0.3% NaOH in 20% n-propanol (pH 13.0 + 3 
0.05) exerts a strong disinfecting activity against bacteria including mycobacteria, fungal 4 
spores, non-enveloped viruses and - prions. This formulation was also effective in the 5 
presence of challenging substrates for disinfection such as dried brain homogenate or 6 
coagulated blood.  7 
While SDS/NaOH (pH 12.8) alone (Lemmer et al., 2004) was virtually inactive on E. faecium 8 
and M. avium, these pathogens were efficiently inactivated by the formulation containing 20% 9 
n-propanol. On the other hand, 20% n-propanol alone did not exert a relevant inactivating 10 
effect on poliovirus, HAV or caliciviruses (including murine norovirus), whereas in 11 
combination with SDS/NaOH effective inactivation of these viruses was observed. While 12 
vegetative forms of fungi are usually quite sensitive to conventional disinfectants spores of 13 
Aspergillus niger are more tolerant (Rutala et al., 2008). However, we observed a pronounced 14 
synergistic effect of SDS/NaOH and 20% n-propanol against spores of Aspergillus niger.  15 
The presence of 20% n-propanol did not compromise the activity against 263K scrapie prions 16 
previously established for SDS/NaOH alone (Lemmer et al., 2004; Lemmer et al., 2008). The 17 
latter finding is of particular importance since alcohols may potentially bind proteins to metal 18 
surfaces (Prior et al., 2004), stabilize PrPTSE and enhance the tolerance of prions to 19 
inactivation (Taylor, 1999). In cases where higher alcohol concentrations would be required 20 
in disinfectant formulations for specific purposes, our findings suggest that adverse effects 21 
that fix or stabilise PrPTSE could be avoided by a two-step procedure: Initial treatment in 22 
SDS/NaOH alone, and subsequent incubation in formulations containing SDS/NaOH as well 23 
as higher concentrated alcohol.   24 
By assessing the decontamination of steel wire grids contaminated with human brain 25 
homogenates from a patient with the most frequent subtype of sporadic CJD (PrPTSE type 1, 26 
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homozygous for methionine at codon 129 of the prion protein gene) that accounts for about 1 
63% of the sCJD cases in Germany (Heinemann et al., 2007), or from a patient with variant 2 
CJD, an at least 2000-fold reduction of the PrPTSE load was demonstrated for SDS/NaOH in 3 
20% n-propanol. This is consistent with the data observed in our study for the disinfection of 4 
steel wires from PrPTSE of 263K scrapie agent. Based on recent findings it has been 5 
recommended, that any prion inactivation procedures should be validated by bioassay against 6 
the prion strain for which they are intended to be used (Giles et al., 2008). This would require 7 
comprehensive experiments in animals. Furthermore, even the best bioassay models 8 
commonly available for vCJD, familial CJD or the six different forms of sCJD (Heinemann et 9 
al., 2007) appear sub-optimal for this purpose in terms of their sensitivity and the rather 10 
limited ranges of titre reduction they would allow to demonstrate only. In order to promote 11 
the further development of effective disinfectants it might be therefore helpful to 12 
comparatively validate candidate formulations against human prions with a focus on the most 13 
relevant human TSEs such as sCJD/subtype MM1 or vCJD. Additionally, alternative 14 
techniques such as protein misfolding cyclic amplification (PMCA) (Castilla et al., 15 
2006;Jones et al., 2007) or novel cell culture assays may be considered as potential surrogate 16 
methods for bioassays in animals.    17 
18  
Protein binding to surfaces by formulations used for disinfection 19 
We performed a qualitative assessment of whether our new disinfectant formulation fixes 20 
organic soil containing proteins to carrier surfaces, and whether the formulation does this 21 
more, or no more, than water or conventional disinfectants such as peracetic acid. In order to 22 
mimick challenging conditions in terms of protein retention, frosted glass strips with a rough 23 
surface were used as test carriers in this assay.  24 
By visual examination our coomassie blue assay indicated that glutardialdehyde and peracetic 25 
acid fixed blood proteins to carrier surfaces as compared to cleaning by water alone, which is 26 
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in accordance with previously reported findings using metal carriers (Kampf et al., 2004) In 1 
contrast, blood contaminated carriers which were incubated in the formulation of 0.2% SDS, 2 
0.3% NaOH and 20% n-propanol did not show a stronger coomassie blue staining than that 3 
observed after cleaning with water. 4 
When brain homogenate was used as organic soil instead of blood, incubation in peracetic 5 
acid again produced a strong staining signal with coomassie blue, while no staining was found 6 
after treatment in glutardialdehyde. Since glutardialdehyde is well known to fix protein  7 
(Kampf et al., 2004) this finding may indicate that glutardialdehyde interferes with the 8 
staining reaction by masking binding sites for coomassie blue. Such potentially interfering 9 
effects, which may also explain that the blood samples treated with glutardialdehyde did not 10 
show a blue coomassie- but rather their original reddish staining, have to be taken into 11 
account when interpreting the findings from our assay. However, they do not seem to account 12 
for the absence of coomassie staining after processing of brain homogenate on glass strips 13 
with NaOCl or SDS/NaOH, since for these formulations efficient cleaning of steel wire 14 
carriers contaminated with 263 K scrapie brain homogenate was already previously 15 
demonstrated by electron microscopy (Lemmer et al., 2008). Thus, with respect to the 16 
observed weak coomassie blue staining of glass carriers after incubation in the formulation of 17 
0.2%SDS, 0.3% NaOH and 20% n-propanol the most obvious conclusion would be that – as 18 
compared to SDS/NaOH alone - some protein was fixed to the carrier surface due to the 19 
presence of alcohol. It has been already previously reported that alcohols may potentially bind 20 
protein to metal surfaces (Prior et al., 2004). However, despite this potential adverse effect of 21 
alcohols, also with brain homogenate the formulation of 0.2% SDS and 0.3% NaOH in 20% 22 
n-propanol was not found to fix proteins more to carrier surfaces than was observed with 23 
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Practical considerations and outlook 1 
Our findings suggest a mixture of 0.2% SDS and 0.3% NaOH in 20% n-propanol as a potent 2 
candidate formulation for the general elimination of infectious agents in the routine 3 
maintenance of surgical steel instruments (including drills used in dentistry). The components 4 
of our formulation are inexpensive and the mixture is simple to prepare. The solution was 5 
found to be effective within 20 min (the uniform exposure time tested on the examined 6 
bacteria, viruses and fungi) or even shorter exposure times tested on prions. As compared to 7 
standard formulations commonly recommended for prion disinfection (e. g. 1-2 M NaOH or 8 
2.5-5 % NaOCl) our mixture appears as a rather mild reagent which much higher 9 
compatibility to steel surfaces, although the alkaline nature of the formulation would still be 10 
corrosive in some situations. N-propanol is easily flammable in higher concentrations and not 11 
odorless, but in the light of the widespread use of alcohol-based hand- and instrument 12 
disinfectants in hospitals these factors do not appear as critical. SDS, NaOH and n-propanol 13 
are potentially toxic, but our formulation can be handled easily and safely under appropriate 14 
conditions of use.  15 
Addressing the disinfection of TSE agents not only in its own right but in combination with 16 
conventional pathogens as recently also reported by others (Lehmann et al., 2009) may open 17 
new avenues for the effective broad-range disinfection of surgical instruments and heat 18 
sensitive medical devices. 19 
 20
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Legends to Tables 1 
Table 1 2 
Efficay of the tested disinfectant formulations on bacteria in a quantitative carrier test 3 
with coagulated blood.    4 
Reduction factors are indicated in log10 units (logs) and were calculated from the difference 5 
between the bacterial load on carriers after processing in the tested formulations and the 6 
bacterial load on carriers after similar processing in dH2O only. Red., reduction in logs. 7 
8  
Table 2 9 
Efficay of the tested disinfectant formulations on viruses as determined by different test 10 
formats.   11 
Reduction factors are indicated and were calculated as specified for table 1. The disinfecting 12 
activities of examined formulations was determined for polio-, hepatitis A- and caliciviruses 13 
by quantitative suspension tests (†). The virucidal activity against poliovirus and hepatitis A 14 
virus in the suspension test was also monitored with an additional organic burden of 10% fetal 15 
calf serum (‡). Inactivation of poliovirus was additionally measured in a quantitative carrier 16 
test with coagulated blood (*). The data for caliciviruses refer to both feline calicivirus and 17 
murine norovirus; however, where specifically indicated values refer to murine norovirus 18 
because of higher observed tolerance (¶). ND, not determined; Red., reduction in logs. 19 
20  
Table 3 21 
Efficay of the tested disinfectant formulations on spores of Aspergillus niger in a 22 
quantitative carrier test with coagulated blood.   23 
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Table 4   1 
Bioassay for prion infectivity on wires coated with 263K scrapie brain homogenate: 2 
Findings after reprocessing in formulations of 0.2% SDS / 0.3% NaOH containing 20% 3 
or 30% n-propanol.  4 
For contamination, wires were incubated in 150 l 10% 263K scrapie brain homogenate, 5 
providing an initial infectivity load of ≥ 3x105 LD50i.c.imp per wire. Survival times until the 6 
development of terminal scrapie are provided in days post implantation (p.im.; mean±SD), 7 
and survival times in bold (>500 days p.im.) refer to hamsters that were sacrificed at the 8 
indicated time points without having developed clinical signs of scrapie. Residual wire 9 
infectivity was deduced from attack rates and survival times using a dose-response 10 
relationship previously established in an end-point titration experiment (Lemmer et al., 2008). 11 
Titre reductions were calculated by comparing the residual infectivity with the contamination 12 
load prior to decontamination. Bioassays were carried out in duplicate (bioassay group 1 and 13 
bioassay group 2). Two (†) or one (‡) out of six challenged animals died for reasons unrelated 14 
to scrapie (accordingly, the number animals in the respective groups was set to n=4 or  n=5, 15 
respectively). Reduction due to rinsing in dH2O could not be quantified in our experimental 16 
setup (*). ND, not determined; Red., reduction in titre [logs]; Res. inf., residual infectivity; 17 
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Legends to Figures 1 
2  
Figure 1 3 
Efficacy of formulations containing 0.2% SDS and 0.3% NaOH in ethanol or  4 
n-propanol for the decontamination of steel surfaces from PrPTSE of 263K scrapie agent.  5 
Western blot detection of full-length PrP and PrP27-30, the proteinase K–resistant core of 6 
PrPTSE, in eluates from contaminated steel wires after incubation in SDS/NaOH formulations 7 
containing 50% ethanol (A) or 50%, 30% or 20% n-propanol (B, C and D, respectively) 8 
without (- PK) or after proteinase K (+ PK) digestion.  9 
(A-D) Lanes 10-6 or 10-7, internal standards: PK-digested brain homogenate from scrapie 10 
hamsters corresponding to 1x10-6 g or 1x10-7 g brain tissue. Lane M, molecular mass marker. 11 
(A-B) Numbered lanes 1-4 represent protein eluates from 30 contaminated wires incubated 12 
for 5 min (lanes 1 and 2) or 20 min (lanes 3 and 4) at 23°C in the formulations. Samples not 13 
subjected to PK digestion (lanes 1 and 3) correspond to 46.2 mm2, PK treated samples (lanes 14 
2 and 4) correspond to 23.1 mm2 of wire surface. (B) Lanes 5 and 6: Eluates (1:10 diluted in 15 
LPP/Urea) from 30 contaminated wires incubated in dH2O for 20 min at 23°C. These samples 16 
correspond to 4.62 mm2 (lane 5) and 2.31 mm2 (lane 6) of wire surface. 17 
(C-D) Numbered lanes 1-4 represent protein eluates from 30 contaminated wires incubated 18 
for 5 min (lanes 1 and 2) or 10 min (lanes 3 and 4) at 23°C in the formulations. Samples not 19 
subjected to PK digestion (lanes 1 and 3) correspond to 46.2 mm2, PK treated samples (lanes 20 
2 and 4) correspond to 23.1 mm2 of wire surface. (D) Lanes 5 and 6: Eluates (1:10 diluted in 21 
LPP/Urea) from 30 contaminated wires incubated in dH2O for 20 min at 23°C. These samples 22 
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Figure 2 1 
Efficacy of formulations containing 0.2% SDS, 0.3% NaOH and n-propanol for the 2 
decontamination of steel surfaces from PrPTSE of CJD- or vCJD agent.  3 
Western blot detection of PrP27-30, the Proteinase K-resistant core of PrPTSE,  in eluates from 4 
contaminated steel wire grids after incubation in the formulations and proteinase K digestion.  5 
(A) Findings for PrPTSE from sCJD (type MM1) brain homogenate. Lanes 1-5, dilution series 6 
of protein eluate from a contaminated steel wire grid (25 l out of a total sample volume of 7 
400 l per grid were diluted 1:100, 1:300, 1:500, 1:1000 and 1:2000). Lanes 6-8, protein 8 
eluates from contaminated grids incubated for 20 min at 23°C in the following formulations: 9 
SDS/NaOH in 20% n-propanol (lane 6), SDS/NaOH in 30% n-propanol (lane 7), and 10 
SDS/NaOH without alcohol (lane 8). Lane 9, protein eluate from a grid incubated initially for 11 
20 min at 23°C in SDS/NaOH without alcohol, and subsequently, again for 20 min at 23°C, in 12 
SDS/NaOH in 30% n-propanol. Samples were digested with proteinase K (20 g/ml) for  13 
20 min. 25 l of the different dilutions and test samples were applied onto lanes 1-9. 14 
(B) Findings for PrPTSE from vCJD brain homogenate. Lanes 1-4, dilution series of protein 15 
eluate from a contaminated steel wire grid (25 l out of a total sample volume of 400 l per 16 
grid were diluted 1:40, 1:100, 1:1000, 1:2000).  Lanes 5-6, protein eluates from contaminated 17 
grids incubated for 5 min at 23°C in the following formulations: SDS/NaOH in 20%  18 
(lane 5) or 30% (lane 6) n-propanol. Samples were digested with proteinase K (20 g/ml) for 19 
10 min. 4 x 25 l of the different dilutions and test samples were successively applied onto 20 
lanes 1-6 (with intermittent electrophoresis for concentrating applied material in the stacking 21 












Figure 3 1 
Protein binding to rough carrier surfaces by various formulations used for disinfection 2 
applied on 10% (w/v) dried hamster brain homogenate (upper panel) or coagulated 3 
sheep blood (lower panel).  4 
Contaminated frosted glas strips were tested in duplicate for residual protein by Coomassie 5 
blue staining after treatment for 30 minutes at 20 °C in 2% glutardialdehyde (GDA, lanes 1 6 
and 2), 0.35% peracetic acid (PAA, lanes 3 and 4), sodium hypochlorite (NaOCl) with 20.000 7 
ppm available chlorine (lanes 5 and 6), formulations of SDS/NaOH (lanes 7 and 8) and 8 
SDS/NaOH in 20% n-propanol (lanes 9 and 10), and ddH2O (lanes 11 and 12). Lane 13: Non-9 
contaminated glas strip incubated for 30 minutes in ddH2O. Neg. Ctrl., negative control.     10 
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Table 1
E. faecium M. avium
Formulation Concen- Time Tempera- Red. Red.
 tration [min] ture [°C] (log10) (log10)
SDS / NaOH 0.2% / 0.3% 20 20 0 0
   
Ethanol 50% 20 20 > 6 > 6
SDS / NaOH 0.2% / 0.3 % 20 20 > 6 > 6
in ethanol in 50%    
n-propanol 20% 20 20 > 6 > 6
SDS / NaOH 0.2% / 0.3 % 20 20 > 6 > 6
in n-propanol in 20%  
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Table 2
Caliciviruses
Formulation Concen- Time Tempera- Red.† and ‡ Red.* Red.† Red.‡ Red.†
 tration [min] ture [°C] (log10) (log10) (log10) (log10) (log10)
SDS / NaOH 0.2% / 0.3% 20 20 > 4 ≤ 4  ≤ 3 ND > 4
   
Ethanol 50% 20 20  < 1   <1.5 < 1 ND < 2¶
SDS / NaOH 0.2% / 0.3 % 20 20 > 4 > 4 ≥  4 > 4 > 5
in ethanol in 50%    
n-Propanol 30% 20 20 < 0.5 ND < 1 ND > 4
20% 20 20 < 0.5 <1.5 < 1 ND < 1¶
SDS / NaOH 0.2% / 0.3 % 20 20 > 4 ND ≥  4 ND > 5
in n-propanol in 30%
0.2% / 0.3 % 20 20 > 4 > 4 > 3 to < 4 > 4 > 5
 in 20%  
Poliovirus Hepatitis A Virus
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Table 3
A. niger
Formulation Concen- Time Tempera- Red.
 tration [min] ture [°C] (log10)
SDS / NaOH 0.2% / 0.3% 20 20 < 0,5
  
Ethanol 50% 20 20 < 1
SDS / NaOH 0.2% / 0.3 % 20 20 > 5
in ethanol in 50%  
n-propanol 20% 20 20 < 1
SDS / NaOH 0.2% / 0.3 % 20 20 > 5
in n-propanol in 20%  
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Table 4
Formulation Concen- Time Tempera- Attack Survival time Res. inf./wire Red. Attack Survival time Res. inf./wire Red.
 tration [min] ture [°C] rate (days p.im.) (LD50i.c.imp) (log10) rate (days p.im.) (LD50i.c.imp) (log10)
None, rinsed in
distilled water only RT 3/3  86±3 ≥ 3x105 -* ND ND ND ND
SDS / NaOH 0.2% / 0.3 % 10 23 0/4† 503 UD ≥ 5.5 0/6 503 UD ≥ 5.5
in n-propanol in 20%            
SDS / NaOH 0.2% / 0.3 % 10 23 0/5‡ 503 UD ≥ 5.5 0/4† 503 UD ≥ 5.5
in n-propanol in 30%     




    ddH2O     N
